Solihull-based Daleswood Health has announced the exclusive regional launch of Exomind, a pioneering non-invasive neuromodulation technology. The innovation is now available for the first time in the Midlands and is positioned at the forefront of modern healthcare solutions. Designed to rebalance neural activity and restore healthy brain function, Exomind represents a new direction in drug-free, personalised treatment.
The technology has been developed to provide an alternative to traditional methods of managing mental and cognitive health. Using gentle stimulation, Exomind works with the body to optimise brain performance and address a spectrum of challenges associated with today’s demanding lifestyles. The scope of its benefits is broad, ranging from reducing anxiety and chronic stress to improving sleep quality and mood regulation. It has also shown promise in supporting people living with ADHD, focus difficulties, and executive dysfunction, alongside aiding recovery from addiction, compulsive behaviours, and emotional or binge eating.
At a time when stress, fatigue, and burnout are becoming increasingly common, particularly among professionals in high-pressure sectors, the introduction of this technology comes as a timely intervention. Exomind’s non-invasive approach is designed to provide individuals with a practical and effective way to improve cognitive resilience and restore balance. Its ability to support workplace wellbeing makes it especially relevant to organisations seeking to enhance employee productivity and performance while also prioritising mental health.
Speaking on the launch, Dr Alison Denton, co-founder of Daleswood Health, said: “We are extremely proud to introduce Exomind to the Midlands community. This technology not only represents the future of personalised brain health, but also has the potential to transform productivity, resilience, and wellbeing in the workplace. At Daleswood Health, our mission is to bring world-class innovations to the region – and Exomind is a significant step forward.” Her words highlight the organisation’s commitment to delivering cutting-edge healthcare solutions tailored to the needs of local communities and businesses.
The exclusive availability of Exomind at Daleswood Health marks an important moment for the Midlands. As awareness of the toll that stress and cognitive overload can take on health and productivity grows, the introduction of a science-led, drug-free option demonstrates the region’s growing role in advancing healthcare innovation. By offering individuals and businesses access to a pioneering tool for mental performance and wellbeing, Daleswood Health is setting a new benchmark for brain health optimisation.
